Autoantibodies Prevalence During Checkpoint Inhibitor Treatment
NCT04220034
·
clinicaltrials.gov ↗
COMPLETED
Status
183
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Adverse Effects of Anti-neoplasic Drug
Interventions
BIOLOGICAL:
Blood sample
Sponsor
CHU de Reims